Merkel Cell Carcinoma Clinical Trials: What Are Prevailing Patient Experiences in Merkel Cell Carcinoma Studies
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Number of patients who decide to enroll in a Merkel cell carcinoma clinical research
研究概览
简要总结
Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged ≥ 18 years old
- •Able to comprehend the investigational nature of the protocol and provide informed consent
- •Diagnosis of Merkel cell carcinoma
排除标准
- •No diagnosis of Merkel cell carcinoma confirmed
- •Inability to perform regular electronic reporting
- •Patient does not understand, sign, and return consent form
结局指标
主要结局
Number of patients who decide to enroll in a Merkel cell carcinoma clinical research
时间窗: 3 months
Rate of patients who remain in Merkel cell carcinoma clinical research to trial completion
时间窗: 12 months
次要结局
未报告次要终点